Chronic GLP-1 Receptor Activation by Exendin-4 Induces Expansion of Pancreatic Duct Glands in Rats and Accelerates Formation of Dysplastic Lesions and Chronic Pancreatitis in the KrasG12D Mouse Model

Gier, Belinda, Matveyenko, Aleksey V., Kirakossian, David, Dawson, David, Dry, Sarah M., Butler, Peter C.·2012·Diabetes
DOI 10.2337/db11-1109

Cited by (256)

Items 201–256 of 256

  1. Weight-centric prevention of cancer
    Diego Añazco, Andres J Acosta, Elizabeth Jane Cathcart-Rake, Stacy D. D’Andre, Maria Daniela Hurtado · 2024 · Obesity Pillars
  2. Semaglutide in Cardiometabolic Diseases: SELECTing the Target Population
    Francesco Natale, Ettore Luisi, Rosa Franzese, Noemi Mollo, Achille Solimene, Valentina Maria Caso, Andrea Corvino, Paolo Golino, Giovanni Cimmino · 2024 · Journal of Cardiovascular Development and Disease
  3. Colitis reducing effects of Lactobacillus plantarum YS-4 in dextran sulfate sodium-induced C57BL/6J mice
    Guijie Li, Xingyao Long, Yanni Pan, Meng Xiao, Xin Zhao · 2018 · Biomedical Research - India
  4. GLP-1 mimetics and diabetic ketoacidosis: possible interactions and clinical consequences
    Forouzanmehr, Behina, Hemmati, Mohammad Amin, Atkin, Stephen L., Jamialahmadi, Tannaz, Yaribeygi, Habib, Sahebkar, Amirhossein · 2025 · Naunyn-Schmiedeberg's Archives of Pharmacology
  5. Problematic Pharmacokinetics: A Case of Recurrent Pancreatitis Post Discontinuation of a Glucagon-Like Peptide 1 Receptor Agonists
    Zachary P. Morehouse, Jack D. Ledford · 2024 · Journal of Pharmacy Practice
  6. Lixisenatide: clinical profile and available evidence
    Ilaria Dicembrini, Michela Bigiarini, Edoardo Mannucci · 2013 · Diabetes Management
  7. Exocrine Pancreas
    Matthew A. Wallig, John L. Vahle, John M. Sullivan · 2024 · Elsevier eBooks
  8. A Case Report of Acute Pancreatitis in Food-Induced Anaphylaxis
    Jennifer Wiese, Bassel Dakkak, Onyinye S Ugonabo, Mohammed El-Dallal, Wesam Frandah · 2024 · Cureus
  9. Expression of the Glucagon Like Peptide-1 Receptor in Human Pancreas and Incretin Therapy
    Gladys Teitelman · 2014 · Endocrinology
  10. Adenocarcinoma of the Pancreas
    Paul Timothy Fanta, Andrew M. Lowy · 2015 · Yamada's Textbook of Gastroenterology
  11. GLP-1
    John A. Williams · 2014
  12. Increased Serum Insulin Exposure Does Not Affect Age or Stage of Pancreatic Adenocarcinoma Diagnosis in Patients With Diabetes Mellitus
    David T. Chao, Nilesh Shah, Herbert J. Zeh, Nathan Bahary, David Clement Whitcomb, Randall E. Brand · 2015 · Pancreas
  13. Sitagliptin-induced Pancreatitis: Chronic Use Would Not Spare You the Complication
    Talal Alkayali, Juan F. Ricardo, Kafayat Adebukola Busari, Ibrahim Saad · 2020 · Cureus
  14. Mild Pancreatitis Induced by Linagliptin Revealed by a Medication Review
    Harish Gidda, Inderpal Singh, Ayman Saber Mohamed, Bola Nashed · 2023 · Cureus
  15. Response to Comment on: Butler et al. A Critical Analysis of the Clinical Use of Incretin-Based Therapies: Are the GLP-1 Therapies Safe? Diabetes Care 2013;36:2118–2125
    Edwin AM Gale · 2013 · Diabetes Care
  16. THE EFFECTS OF METFORMIN ON PANCREATIC CANCER METABOLISM
    Mary Jo Cantoria · 2014 · UA Campus Repository (The University of Arizona)
  17. Improvement of Decision Support System for Rail Depot Planning
    Berkay Beygo · 2013
  18. Obesity management medications for the surgeon
    Matthew Harris, Shareef Mahdi, Cameron J. Fairfield, Leo R. Brown, Martin Wadley, Alexander Dimitri Miras · 2026 · Frontline Gastroenterology
  19. Risk of pancreatic cancer associated with GLP-1 receptor agonist therapy
    Shreyas Krishna, Kathleen Marie Dungan, Raj Shah, Zobeida Cruz‐Monserrate, Kathleen E. DelGiorno, Marcus Tan, Phil A. Hart · 2026 · npj gut and liver.
  20. Glucagon-like peptide-1 based therapies: Effects beyond blood glucose control
    Subash Sivaraman, Thomas M. Barber, Paul J. O'Hare, Harpal Singh Randeva · 2013 · The British Journal of Diabetes
  21. GPR40 Modulators: New Kid on the Block
    Ananda Basu, Yogish C. Kudva, Rita Basu · 2013 · Diabetes Care
  22. Incretin-Based Therapies: Revisiting Their Mode of Action
    Brian Thomas Layden, Barton L. Wicksteed, Franck Mauvais‐Jarvis · 2017 · Endocrinology
  23. Exendin-4 dose not evoke pancreatitis or pancreatitis-associated histopathological and genetic changes in high-fat diet induced diabetic mice
    Yi Qiong Sun, Chang Yue Guo, Qiang Li, Lin Guo, Li Chen, Wei Wang, Jin Chao Zhang · 2018 · Biomedical Research - India
  24. Necrotizing Pancreatitis Secondary to Hydrochlorothiazide and Alogliptin: A Case Report
    Teresa Del Rio, Manveer Ubhi, Luis E Irizarry Nieves, Basilides Fermin, Kala Sury · 2023 · Cureus
  25. Drug-associated pancreatic cancer: insights from real-world pharmacovigilance and network pharmacology
    Hao Xie, Qiang Xu, Bin Zhao, Wenming Wu · 2025 · Expert Opinion on Drug Safety
  26. An Unusual Case of Drug-Induced Acute Pancreatitis
    Andrea T. Vo, Stanley Yakubov, COLLEEN M. SMITH, Mark Tratenberg, Elizabeth Sedlis-Singer, Vijay Shetty · 2016 · Einstein Journal of Biology and Medicine
  27. [Exenatide promotes cholesterol efflux in pancreatic tissue of obese diabetic rats].
    Lei Zhao, X Zhang, J Feng, Z Xiao, Y Liu, H Long, Xinyu Chen, Weiqiang Tang · 2021 · PubMed Central
  28. Combinatorial Targeting of the Glucagon-Like Peptide-1 And Sulfonylurea-1 Receptors Using a Complimentary Multivalent Glucagon-Like Peptide-1/Glibenclamide Ligand for the Improvement of β-Cell Targeting Agents and Diabetic Treatment
    Nathaniel J. Hart · 2013 · UA Campus Repository (The University of Arizona)
  29. Glucagon-like peptide-1 in nonalcoholic steatohepatitis
    Matthew James Armstrong · 2014 · University of Birmingham Institutional Research Archive (University of Birmingham)
  30. Cancers du pancréas et sécurité des incrétines : état des lieux en 2014
    S. Halimi · 2014 · Médecine des Maladies Métaboliques
  31. Effect of DPP-4 Inhibitors on the Cardiovascular System, Cancer and Pancreatitis
    Eun-Hee Cho · 2013 · Journal of Korean Diabetes
  32. Pharmacologic Approach to Type 2 Diabetes in Obese Patients
    León Litwak, Carla Musso, Susana Fuentes · 2014 · Springer eBooks
  33. Debate on diabetes drugs gathers pace
    Amy Maxmen · 2012 · Nature
  34. Improved β-Cell Targeting and Therapeutics Using Multivalent Glucagon-Like Peptide-1 (GLP-1) Linked to the α2AR Antagonist Yohimbine (YHB): Evaluating the Binding, Selectivity and Signaling
    Kameswari Ananthakrishnan · 2016 · UA Campus Repository (The University of Arizona)
  35. Acute pancreatitis with dipeptidyl peptidase-4 (DPP4) inhibitor or fulminant type 1 diabetes?
    Chloé Amouyal, Philippe Lévy, Fabrizio Andréelli, Agnès Hartemann · 2017 · Diabetes & Metabolism
  36. A Novel Peptide with Similar Pharmacology to Exenatide in Rodents as GLP-1 Receptor Agonist
    Guangji Zhang, Licheng Wang, Jia Xu, Yue Zhang, Mingyang Wang, Qifei Wang, Kai Wang, Liping Wang · 2017 · International Journal of Peptide Research and Therapeutics
  37. Molecular Imaging Agent Design for Quantifying Beta Cell Mass in Type 1 Diabetes
    Liang Zhang · 2017 · Deep Blue (University of Michigan)
  38. Insight in disease and drug interactions, with treatment optimisation of patients with cancer
    Knapen · 2019
  39. Type 2 diabetes mellitus and gastrointestinal cancer
    de Jong · 2019
  40. Thérapeutique des désordres glycémiques
    2014 · Elsevier eBooks
  41. Thérapeutique des désordres glycémiques
    2019 · Elsevier eBooks
  42. Current World Literature
    2013 · Current Opinion in Organ Transplantation
  43. GLP-1
    John A. Williams · 2021
  44. Effekte einer Therapie mit Liraglutid bei Jugendlichen mit extremer Adipositas unter Real-Life-Bedingungen
    Melanie Schirmer, Stephanie Brandt, Stefanie Zorn, Martin Wabitsch · 2023 · Adipositas - Ursachen Folgeerkrankungen Therapie
  45. Rapid Progression of Papillary Thyroid Carcinoma Following Initiation of Semaglutide (Wegovy) for Weight Loss: A Case Report
    Miranda Stiewig-Rapp, Hiba Basheer · 2025 · International Journal of Clinical and Translational Medicine
  46. Dual Benefits and Risks: Tirzepatide's Impact on Pancreatic Function
    Sabina Florina Șolea, Amina Venter, Lavinia Davidescu, Brisc Mihaela Cristina, B.M. Mihai, Darius Davidescu, Anca Goman, Mousa El-kharoubi, Selena Ioana El-Kharoubi, Alexandra Orășeanu et al. · 2025 · Internal Medicine
  47. Glucagon-like Peptide-1 Receptor Agonists and Gastrointestinal Neoplasms
    Yu Jin Kim, Jaehyun Bae · 2025 · Journal of Digestive Cancer Research
  48. Intraductal papillary mucinous neoplasm worsening glycemic control in a patient with type 2 diabetes mellitus
    Ron T. Varghese, Ugur Deniz Ayar, Mariana Zamin, Feranmi Oyalade, Viviana Valencia, Marie Louise Aoun · 2026 · The American Journal of the Medical Sciences
  49. Risk of Diabetic Ketoacidosis with Glucagon-Like Peptide-1 Receptor Agonists: A Systematic Review and Meta-analysis
    Nasser Alkhushaym, Wadha Almutairi, SHAHAD ALANAZI, Reem Balharith, Abdullah A. Alhifany, Imad R. Musa · 2026 · Research Square
  50. Unconventional Applications of Semaglutide and Tirzepatide: From Oncology to Human Reproduction
    Sandro La Vignera, Rosita Angela Condorelli · 2026 · Biomedicines
  51. Glucagon-like peptide-1 receptor agonists and pancreatic cancer risk: Balancing reassurance and vigilance
    Jianing Li, Shounak Majumder · 2026 · Pancreatology
  52. Can GLP-1 receptor agonists be used after an episode of acute pancreatitis? Reconciling emerging evidence with regulatory caution
    Cole R Smith · 2026 · Considerations in Medicine
  53. Impact of GLP-1 receptor agonists on patients with intraductal papillary mucinous neoplasms: Study protocol for a multicentric cohort study
    Melissa Lagger, Hugo Najberg, Almir Miftaroski, Lucien Widmer, Sara Di Renzo, Pouya Iranmanesh, Maxime Matter, Boran Tekdogan, Stéphanie Fabienne Perrodin, Beat Gloor et al. · 2026 · PLoS ONE
  54. The Dark Side of GLP-1 Receptor Agonists: Risks and Adverse Events
    C L Nawal, Hazari Lal Saini, Govind Rankawat, Radhey Shyam Chejara · 2026 · Journal of the Association of Physicians of India
  55. Glucagon-like Peptide-1 Receptor Agonists Are Not Associated with Increased Risk of Acute Pancreatitis or Pancreatic Complications, Including Pancreatic Cancer, in Type 2 Diabetes: A Global Propensity-Matched Cohort Study
    Yan Sun, Benjamin Liu, Hanyou Loh, Samantha Mathialagan, Cindy Hsin-Ti Lin, Yasir Tarabichi, Donovan Veccia, Richard Wong, William W. Tse, Gengqing Song · 2026 · Journal of Personalized Medicine
  56. Proliferation of Pancreatic Heterotopia Following Semaglutide Therapy: A Case Report of a Possible Association
    Abdullah Al-awad, Alexander Barsegian, Priscilla Phan, Mustafa Kinaan · 2026 · AACE Endocrinology and Diabetes